DD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dupont De Nemours Inc (DD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows potential for growth based on recent analyst ratings, positive technical indicators, and congress trading data indicating confidence in the stock. While there are no strong short-term trading signals, the stock's fundamentals and long-term prospects make it a suitable choice for the investor's profile.
The technical indicators for DD are generally positive. The MACD histogram is above 0 and positively contracting, indicating bullish momentum. The RSI is neutral at 50.534, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading above its key support level of 47.273, with resistance levels at 49.042 and 50.135.
Congress trading data shows a recent purchase transaction in the range of $0.1M to $1.5M, indicating confidence from influential figures.
Analysts have raised price targets recently, with RBC Capital, Deutsche Bank, and UBS setting targets between $59 and $60, reflecting optimism about the company's growth potential.
The company's strategic shift towards healthcare and water technologies is expected to drive organic growth and margin expansion.
Regular market change shows a slight decline of -0.50%, indicating short-term weakness.
Goldman Sachs has a Neutral rating, citing below-average revenue and earnings growth estimates compared to peers.
The Building & Construction segment faces weakness, and higher costs due to geopolitical conflicts may impact margins.
No financial data available for the latest quarter. However, analysts expect mid-single-digit revenue growth translating into high-single-digit EBITDA and low-double-digit EPS growth, supported by cost optimization strategies.
Analyst sentiment is mixed but leans positive. RBC Capital, Deutsche Bank, and UBS have Buy ratings with price targets between $59 and $60. Goldman Sachs and BofA maintain Neutral ratings with lower price targets, citing concerns over growth estimates and raw material inflation. Overall, the average price target suggests upside potential from the current price of $47.93.
